CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes

European Journal of Immunology

Volumn 31, Issue 1, 2001, Pages 301-310

  Ballingall, Keith T ^a,b   MacHugh, Niall D ^a   Taracha, Evans L N ^a   Mertens, Bea ^a   McKeever, Declan J ^a,c  

^a INTERNATIONAL LIVESTOCK RESEARCH INSTITUTE   (Kenya)

^b MOREDUN RESEARCH INSTITUTE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Antigen presentation; Chemokine; DNA vaccine; MHC class II; Myocyte

Indexed keywords

CHEMOKINE; DNA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL COMPARTMENTALIZATION; GENETIC TRANSFECTION; HEART MUSCLE CELL; IMMUNE RESPONSE; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; CHEMOKINES; DINUCLEOSIDE PHOSPHATES; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNIZATION; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MUSCLES; VACCINES, DNA;

EID: 0035137604     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200101)31:1<301::AID-IMMU301>3.0.CO;2-K     Document Type: Article

References (43)

1. The immunobiology of muscle
2. Myoblasts fail to stimulate T cells but induce tolerance
3. A cell culture model for T lymphocyte clonal anergy
4. Genetic immunization: A new era in vaccines and immune therapeutics
5. Exposing the immunology of naked DNA vaccines
6. The immunologist's grail
7. Genetic immunization
8. DNA vaccines
9. Priming of cytotoxic T lymphocytes by DNA vaccines: Requirement for professional antigen oresenting cells and evidence for antigen transfer from myocytes
10. Generation of MHC class 1-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells
11. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites
12. Gene vaccination with naked plasmid DNA: Mechanism of CTL priming
13. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations
14. DNA-based immunization by in vivo transfection of dendritic cells
15. Antigen presentation by dendritic cells aftger immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope
16. Induction of HLA-DR expression on human myoblasts with interferon-gamma
17. Human myoblasts as antigen-presenting cells
18. Elevated MHC class-I and class-II antigens in cultured human embryogenic myoblasts following stimulation with gamma-interferon
19. Expression of major histocompatibility complex antigens on human myoblasts
20. Modulation of MHC class II antigen expression in human myoblasts after treatment with INF-γ
21. Inflammatory and toxic myopathies
22. CpG motifs present in bacteria DNA rapidly induce lymphocyte to secrete interleukin 6, interleukin 12, and interferon gamma
23. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
24. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
25. Lymphocyte responses to chemokines
26. Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule
27. From epitopes to peptides to immunotherapy
28. Schwann cells cocultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: Synergistic effects of interferon gamma and tumor necrosis factor on MHC class II induction
29. Schwann cells and myasthenia gravis: Preferential uptake of soluble and membrane bound AChR by normal and immortalized Schwann cells, and immunogenic presentation to AChR-specific T line lymphocytes
30. + lymphocytes by singeneic brain microvascular smooth muscle cells
31. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in rats
32. Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation
33. Antigen presentation by human dermal microvascular endothelial cells
34. The human mixed lymphocyte-endothelium culture interaction
35. Binding of immunogenic peptides to la histocompatibility molecules
36. MHC class II-restricted presentation of intracellular antigen
37. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis
38. Class II MHC molecules can use the endogenous pathway of antigen presentation
39. CpG motifs in bacterial DNA trigger direct B-cell activation
40. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
41. Protective immunity elicited by vaccination with DNA encoding for a B cell and a T cell epitope of the A/PR/8/34 influenza virus
42. Specific low-affinity recognition of MHC complex plus peptide by soluble T-cell receptor
43. Immunolocalization of granulocyte-colony-stimulating factor in human glial and primitive neuroectodermal tumors